サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1764874

アジア太平洋の臓器保存ソリューション市場の2031年までの予測-地域別分析- 製品、用途、タイプ、エンドユーザー別

Asia Pacific Organ Preservation Solution Market Forecast to 2031 - Regional Analysis - by Product, Application, Type, and End User

出版日
ページ情報
英文 138 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
アジア太平洋の臓器保存ソリューション市場の2031年までの予測-地域別分析- 製品、用途、タイプ、エンドユーザー別
出版日: 2025年04月17日
発行: The Insight Partners
ページ情報: 英文 138 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の臓器保存ソリューション市場は、2023年に3,797万8,810米ドルと評価され、2031年には8,119万9,780米ドルに達すると予測され、2024～2031年のCAGRは10.1%と推定されます。

市場参入企業の戦略的取り組みがアジア太平洋の臓器保存ソリューション市場を後押し

さまざまな開発企業が、慢性疾患の治療を容易にする先進的製品を開発するため、製品の発売や戦略的提携に注力しています。ここ数年、製品の発売、合併、買収など、最近の動向はさまざまです。

2022年4月、トランスメディックスグループは、循環死後のドナーから調達した臓器を使用するためのOCS心臓システムの市販前承認をFDAから取得しました。OCS心臓システムは、循環死後ドナー（DCD）心臓の生体外蘇生、機能モニタリング、心拍保存の臨床適応拡大で承認されました。

2023年8月、臓器移植の主要企業であるパラゴニクス Technologiesは、次世代ドナー肺保存システムBAROguardのFDA認可を取得しました。BAROguardシステムは、パラゴニクスの先進的な低体温保存技術と、自動化された連続的かつ能動的な気道圧制御を組み合わせたものです。この制御により、ドナーからレシピエントへの移送中、ドナーの肺の最適な温度範囲と臨床的に推奨される膨張圧範囲の維持が保証されます。この先進技術の斬新な組み合わせは、移植医療セグメントにおける標準治療の改善と再定義に対する当社の継続的なコミットメントをさらに強化するものです。

2024年4月、Mayo ClinicとTerasaki Institute for Biomedical Innovationは、臓器移植の転帰を改善するために協力しました。Mayo Clinicの生物医療研究者と寺崎ラボの科学者は、提供された臓器の調達から移植手術までのリアルタイムモニタリングと、拒絶反応のリスクが高い移植レシピエントを特定するための予測技術の開発という2つの主要な研究セグメントで協力する予定です。これには、予後予測シグネチャーの作成と、臓器移植における抗体介在性拒絶反応のアッセイが含まれます。初期プロジェクトは24～30ヶ月以内に完了する予定です。

このように、製品の承認、上市、戦略的提携の急増は、将来的に臓器保存ソリューション市場に大きな成長機会をもたらす可能性が高いです。

アジア太平洋の臓器保存ソリューション市場概要

アジア太平洋の臓器保存ソリューション市場は、中国、日本、インド、オーストラリア、韓国、その他のアジア太平洋のに区分されます。同地域の市場成長は、アジア太平洋の諸国の臓器移植件数の増加、高齢化人口の増加、臓器不全につながる慢性疾患の有病率の上昇、臓器保存ソリューションの開発・改良の増加に起因しています。中国はアジア太平洋のにおける臓器保存ソリューションの最大市場になると予想されています。同国の市場成長は、臓器移植を求める慢性疾患の有病率の高さに起因しています。最近の研究「中国の慢性疾患と高齢化」によると、中国では人口の高齢化が進み、慢性疾患がますます蔓延しています。中国における60歳以上の高齢者の割合は、2010～2040年までに12.4%から28%に増加すると予想されています。中国では、60歳以上の死亡原因の約80％が慢性非感染性疾患（NCDs）であると報告されています。慢性閉塞性肺疾患（COPD）、脳卒中、虚血性心疾患、2型糖尿病は、中国で最も流行している疾患のひとつです。中国は世界の他の国に比べて肝臓がんの罹患率が高いです。世界保健機関（WHO）によると、中国では毎年約40万人が肝臓がんと診断され、約36万8000人が肝臓がんが原因で死亡しています。世界人口の20％以下であるにもかかわらず、中国は新規肝がん症例のほぼ半分を占めています。肝細胞がん（HCC）は原発性肝がんの約90％を占めます。肝細胞がんは、主に慢性B型肝炎やC型肝炎による肝硬変や瘢痕化した患者に開発されます。糖尿病や肝がんのような慢性疾患は臓器障害を引き起こします。そのため、中国では臓器移植の必要性が高まっており、臓器保存ソリューションの需要が高まっています。

アジア太平洋の臓器保存ソリューション市場の収益と2031年までの予測（千米ドル）

アジア太平洋の臓器保存ソリューション市場セグメンテーション

アジア太平洋の臓器保存ソリューション市場は、製品、用途、タイプ、エンドユーザー、国に分類されます。

製品別では、アジア太平洋の臓器保存液市場はウィスコンシン大学ソリューション、カストジオールHTK、パーファデックス、ハイポサーモゾール、その他に分類されます。2023年にはウィスコンシン大学セグメントが最大の市場シェアを占めています。

用途別では、アジア太平洋の臓器保存ソリューション市場は、静的冷蔵保存、低体温機械灌流、常温機械灌流、その他に区分されます。2023年には、静的低温保存セグメントが最大の市場シェアを占めています。

タイプ別では、アジア太平洋の臓器保存ソリューション市場は腎臓、肝臓、肺、心臓、その他に分類されます。腎臓セグメントが2023年に最大の市場シェアを占めました。

エンドユーザー別に見ると、アジア太平洋の臓器保存ソリューション市場は、臓器移植センター、病院、専門クリニックに分類されます。臓器移植センターセグメントが2023年に最大の市場シェアを占めました。

国別では、アジア太平洋の臓器保存ソリューション市場は、中国、日本、インド、オーストラリア、韓国、その他のアジア太平洋のに区分されます。2023年のアジア太平洋の臓器保存ソリューション市場シェアは中国が独占しました。

XVIVO Perfusion、TransMedics、Dr. Franz Koehler Chemie GmbH、Accord Healthcare、Shanghai Genext Pharmaceutical Technologyは、アジア太平洋の臓器保存ソリューション市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察
  • 市場の魅力

第3章 調査手法

  • 二次調査
  • 一次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 アジア太平洋の臓器保存ソリューション市場：主要市場力学

  • 市場促進要因
    • 臓器移植ニーズの高まり
    • 慢性疾患の有病率の増加
  • 市場抑制要因
    • 高額な臓器移植手術
    • 臓器の入手可能性の制限
  • 市場機会
    • 市場参入企業による戦略的取り組み
  • 今後の動向
    • 機械灌流技術へのシフト
  • 促進要因と抑制要因の影響

第5章 臓器保存ソリューション市場：アジア太平洋の分析

  • 臓器保存ソリューション市場の収益（2021～2031年）
  • 臓器保存ソリューション市場予測分析

第6章 アジア太平洋の臓器保存ソリューション市場分析-製品別

  • ウィスコンシン大学ソリューション
  • カストジオールHTK
  • パーファデックス
  • ハイポサーモゾール
  • その他

第7章 アジア太平洋の臓器保存ソリューション市場分析-用途別

  • 静的冷蔵保存
  • 低体温機械灌流
  • 常温機械灌流
  • その他

第8章 アジア太平洋の臓器保存ソリューション市場分析-タイプ別

  • 腎臓
  • 肝臓
  • 肺
  • 心臓
  • その他

第9章 アジア太平洋の臓器保存ソリューション市場分析-エンドユーザー別

  • 臓器移植センター
  • 病院
  • 専門クリニック

第10章 アジア太平洋の臓器保存ソリューション市場：国別分析

  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他のアジア太平洋

第11章 臓器保存ソリューション市場-産業情勢

  • イントロダクション
  • 臓器保存ソリューション市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • XVIVO Perfusion
  • TransMedics
  • Dr. Franz Koehler Chemie GmbH
  • Accord Healthcare
  • Shanghai Genext Pharmaceutical Technology

第13章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Organ Preservation Solution Market Segmentation
  • Table 2. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Table 3. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 4. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 5. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 6. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 7. Asia Pacific: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Country
  • Table 8. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 9. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 10. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 11. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 12. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 13. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 14. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 15. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 16. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 17. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 18. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 19. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 20. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 21. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 22. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 23. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 24. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 25. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 26. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 27. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 28. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 29. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 30. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 31. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 32. Recent Organic Growth Strategies in Organ Preservation Solutions Market
  • Table 33. Recent Inorganic Growth Strategies in the Organ Preservation Solutions Market
  • Table 34. Glossary of Terms, Organ Preservation Solution Market

List Of Figures

  • Figure 1. Asia Pacific Organ Preservation Solution Market Segmentation, by Country
  • Figure 2. Organ Preservation Solution Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Organ Preservation Solution Market Revenue (US$ Thousand), 2021-2031
  • Figure 5. Organ Preservation Solution Market Share (%) - by Product (2023 and 2031)
  • Figure 6. University of Wisconsin Solution: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 7. Custodiol HTK: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 8. Perfadex: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 9. HypoThermosol: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 10. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 11. Organ Preservation Solution Market Share (%) - by Application (2023 and 2031)
  • Figure 12. Static Cold Storage: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 13. Hypothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 14. Normothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 15. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 16. Organ Preservation Solution Market Share (%) - by Type (2023 and 2031)
  • Figure 17. Kidneys: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 18. Liver: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 19. Lungs: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 20. Heart: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 21. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 22. Organ Preservation Solution Market Share (%) - by End User (2023 and 2031)
  • Figure 23. Organ Transplant Centers: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 24. Hospitals: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 25. Specialty Clinics: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 26. Asia Pacific Organ Preservation Solution Market, by Key Country - Revenue (2023) (US$ Thousand)
  • Figure 27. Asia Pacific: Organ Preservation Solution Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 28. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 29. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 30. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 31. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 32. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 33. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 34. Growth Strategies in Organ Preservation Solutions Market
目次
Product Code: TIPRE00025780

The Asia Pacific organ preservation solution market was valued at US$ 37,978.81 thousand in 2023 and is expected to reach US$ 81,199.78 thousand by 2031; it is estimated to register a CAGR of 10.1% from 2024 to 2031.

Strategic Initiatives by Market Players Fuels Asia Pacific Organ Preservation Solution Market

Various market players focus on product launches or strategic collaborations to develop advanced products that help ease the treatment of chronic disorders. There have been various recent developments, such as product launches, mergers, and acquisitions in recent years.

In April 2022, TransMedics Group, Inc. received premarket FDA approval for its OCS Heart System for using it with organs procured from donors after circulatory death. The OCS Heart System is approved with the extended clinical indication for ex vivo reanimation, functional monitoring, and beating-heart preservation of donors-after-circulatory-death (DCD) hearts.

In August 2023, Paragonix Technologies, a leading organ transplant company, received FDA clearance for its next-generation donor lung preservation system-BAROguard. The BAROguard system combines Paragonix's advanced hypothermic preservation technology with automated continuous and active airway pressure control. This control ensures the maintenance of optimal temperature range and a clinically recommended inflation pressure range for donor's lungs throughout their transfer from donors to recipients. This novel combination of advanced technologies further reinforces the company's ongoing commitment to improving and redefining the standard of care within the field of transplant medicine.

In April 2024, the Mayo Clinic and the Terasaki Institute for Biomedical Innovation collaborated to improve organ transplant outcomes. Mayo Clinic biomedical researchers and Terasaki Institute scientists plan to collaborate on two main study areas: real-time monitoring of donated organ health from procurement to transplant surgery and the development of predictive technologies to identify transplant recipients with a higher risk of rejection. This will involve creating prognostic signatures and assays for antibody-mediated rejection of organ transplants. The initial projects are expected to be completed within 24-30 months.

Thus, a surge in product approvals, launches, and strategic collaborations is likely to create considerable growth opportunities for the organ preservation solution market in the future.

Asia Pacific Organ Preservation Solution Market Overview

The organ preservation solution market in Asia Pacific is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in the region is attributed to the growing number of organ transplantations across several countries in Asia Pacific, increasing aging population, rising prevalence of chronic diseases that lead to organ failure, and increasing developments and improvements in organ preservation solutions. China is expected to be the largest market for organ preservation solutions in Asia Pacific. The market growth in the country is attributed to the high prevalence of chronic diseases seeking organ transplantation. According to a recent study, "Chronic Illness and Ageing in China," China's population is aging, and chronic illnesses are increasingly prevalent in the country. The proportion of people aged 60 years and above in China is expected to rise from 12.4% to 28% from 2010 to 2040. In China, ~80% of deaths of people aged 60 years are reported due to chronic noncommunicable diseases (NCDs). Chronic obstructive pulmonary disease (COPD), stroke, ischemic heart disease, and type 2 diabetes are among the most prevalent diseases in the country. China has a greater rate of liver cancer than other countries across the world. According to the World Health Organization, ~400,000 people are diagnosed with liver cancer, and around 368,000 people die due to the disease in China every year. Although accounting for less than 20% of the global population, China accounts for nearly half of all new liver cancer cases. Hepatocellular carcinoma (HCC) represents roughly 90 % of all occurrences of primary liver cancer. It develops mainly in those patients with cirrhosis, or scarring, due to chronic hepatitis B or C. Chronic diseases such as diabetes and liver cancer lead to organ damage. Therefore, the need for organ transplants has increased in China, bolstering the demand for organ preservation solutions.

Asia Pacific Organ Preservation Solution Market Revenue and Forecast to 2031 (US$ Thousand)

Asia Pacific Organ Preservation Solution Market Segmentation

The Asia Pacific organ preservation solution market is categorized into product, application, type, end user, and country.

Based on product, the Asia Pacific organ preservation solution market is categorized into University of Wisconsin solution, custodiol HTK, Perfadex, HypoThermosol, and others. The University of Wisconsin segment held the largest market share in 2023.

In terms of application, the Asia Pacific organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest market share in 2023.

By type, the Asia Pacific organ preservation solution market is categorized into kidneys, liver, lungs, heart, and others. The kidneys segment held the largest market share in 2023.

Based on end user, the Asia Pacific organ preservation solution market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest market share in 2023.

By country, the Asia Pacific organ preservation solution market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific organ preservation solution market share in 2023.

XVIVO Perfusion, TransMedics, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, and Shanghai Genext Pharmaceutical Technology, are among the leading companies operating in the Asia Pacific organ preservation solution market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Organ Preservation Solution Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Need for Organ Transplantation
    • 4.1.2 Increasing Prevalence of Chronic Diseases
  • 4.2 Market Restraints
    • 4.2.1 Expensive Organ Transplant Surgeries
    • 4.2.2 Limited Organ Availability
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives by Market Players
  • 4.4 Future Trends
    • 4.4.1 Shift Toward Machine Perfusion Technique
  • 4.5 Impact of Drivers and Restraints:

5. Organ Preservation Solution Market - Asia Pacific Analysis

  • 5.1 Organ Preservation Solution Market Revenue (US$ Thousand), 2021-2031
  • 5.2 Organ Preservation Solution Market forecast Analysis

6. Asia Pacific Organ Preservation Solution Market Analysis - by Product

  • 6.1 University of Wisconsin Solution
    • 6.1.1 Overview
    • 6.1.2 University of Wisconsin Solution: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 6.2 Custodiol HTK
    • 6.2.1 Overview
    • 6.2.2 Custodiol HTK: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 6.3 Perfadex
    • 6.3.1 Overview
    • 6.3.2 Perfadex: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 6.4 HypoThermosol
    • 6.4.1 Overview
    • 6.4.2 HypoThermosol: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 6.5 Others
    • 6.5.1 Overview
    • 6.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

7. Asia Pacific Organ Preservation Solution Market Analysis - by Application

  • 7.1 Static Cold Storage
    • 7.1.1 Overview
    • 7.1.2 Static Cold Storage: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 7.2 Hypothermic Machine Perfusion
    • 7.2.1 Overview
    • 7.2.2 Hypothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 7.3 Normothermic Machine Perfusion
    • 7.3.1 Overview
    • 7.3.2 Normothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

8. Asia Pacific Organ Preservation Solution Market Analysis - by Type

  • 8.1 Kidneys
    • 8.1.1 Overview
    • 8.1.2 Kidneys: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 8.2 Liver
    • 8.2.1 Overview
    • 8.2.2 Liver: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 8.3 Lungs
    • 8.3.1 Overview
    • 8.3.2 Lungs: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 8.4 Heart
    • 8.4.1 Overview
    • 8.4.2 Heart: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

9. Asia Pacific Organ Preservation Solution Market Analysis - by End User

  • 9.1 Organ Transplant Centers
    • 9.1.1 Overview
    • 9.1.2 Organ Transplant Centers: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 9.2 Hospitals
    • 9.2.1 Overview
    • 9.2.2 Hospitals: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 9.3 Specialty Clinics
    • 9.3.1 Overview
    • 9.3.2 Specialty Clinics: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

10. Asia Pacific Organ Preservation Solution Market - Country Analysis

  • 10.1 Asia Pacific
    • 10.1.1 Asia Pacific: Organ Preservation Solution Market Breakdown, by Key Country, 2023 and 2031 (%)
      • 10.1.1.1 Asia Pacific: Organ Preservation Solution Market - Revenue and forecast Analysis - by Country
      • 10.1.1.2 China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.2.1 China: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.2.2 China: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.2.3 China: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.2.4 China: Organ Preservation Solution Market Breakdown, by End User
      • 10.1.1.3 Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.3.1 Japan: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.3.2 Japan: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.3.3 Japan: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.3.4 Japan: Organ Preservation Solution Market Breakdown, by End User
      • 10.1.1.4 India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.4.1 India: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.4.2 India: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.4.3 India: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.4.4 India: Organ Preservation Solution Market Breakdown, by End User
      • 10.1.1.5 Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.5.1 Australia: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.5.2 Australia: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.5.3 Australia: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.5.4 Australia: Organ Preservation Solution Market Breakdown, by End User
      • 10.1.1.6 South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.6.1 South Korea: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.6.2 South Korea: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.6.3 South Korea: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.6.4 South Korea: Organ Preservation Solution Market Breakdown, by End User
      • 10.1.1.7 Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.7.1 Rest of APAC: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.7.2 Rest of APAC: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.7.3 Rest of APAC: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.7.4 Rest of APAC: Organ Preservation Solution Market Breakdown, by End User

11. Organ Preservation Solutions Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Organ Preservation Solutions Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 XVIVO Perfusion
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 TransMedics
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Dr. Franz Koehler Chemie GmbH
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Accord Healthcare
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Shanghai Genext Pharmaceutical Technology
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms